PRPO logo

Precipio, Inc. Stock Price

NasdaqCM:PRPO Community·US$42.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

PRPO Share Price Performance

US$23.80
13.76 (137.05%)
US$23.80
13.76 (137.05%)
Price US$23.80

PRPO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks
1 Reward

Precipio, Inc. Key Details

US$25.8m

Revenue

US$14.5m

Cost of Revenue

US$11.3m

Gross Profit

US$12.2m

Other Expenses

-US$922.0k

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.52
43.71%
-3.57%
0.5%
View Full Analysis

About PRPO

Founded
n/a
Employees
66
CEO
Ilan Danieli
WebsiteView website
www.precipiodx.com

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Recent PRPO News & Updates

Recent updates

No updates